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Role of Dlx6 in regulation
of an endothelin-1-dependent,
dHAND branchial arch enhancer
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Masashi Yanagisawa,2,4 James A. Richardson,3 and Eric N. Olson1,9
1Department of Molecular Biology, 2Department of Molecular Genetics, 3Department of Pathology, and 4Howard Hughes
Medical Institute, University of Texas Southwestern Medical Center, Dallas, Texas 75239-9148, USA; 5Laboratory
of Molecular Morphogenesis, National Cancer Institute–I.S.T., 16132 Genova, Italy; 6Laboratoire de Physiologie, Museum
National d’Histoire Naturelle, UMR CNRS 8572, Paris, France
Neural crest cells play a key role in craniofacial development. The endothelin family of secreted polypeptides
regulates development of several neural crest sublineages, including the branchial arch neural crest. The basic
helix–loop–helix transcription factor dHAND is also required for craniofacial development, and in
endothelin-1 (ET-1) mutant embryos, dHAND expression in the branchial arches is down-regulated,
implicating it as a transcriptional effector of ET-1 action. To determine the mechanism that links ET-1
signaling to dHAND transcription, we analyzed the dHAND gene for cis-regulatory elements that control
transcription in the branchial arches. We describe an evolutionarily conserved dHAND enhancer that requires
ET-1 signaling for activity. This enhancer contains four homeodomain binding sites that are required for
branchial arch expression. By comparing protein binding to these sites in branchial arch extracts from
endothelin receptor A (EdnrA) mutant and wild-type mouse embryos, we identified Dlx6, a member of the
Distal-less family of homeodomain proteins, as an ET-1-dependent binding factor. Consistent with this
conclusion, Dlx6 was down-regulated in branchial arches from EdnrA mutant mice. These results suggest that
Dlx6 acts as an intermediary between ET-1 signaling and dHAND transcription during craniofacial
morphogenesis.
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The neural crest, which is induced at the interface be-
tween ectoderm and neurectoderm (for review, see Gar-
cía-Castro and Bronner-Fraser 1999), is a key vertebrate
character. Neural crest cells emigrate from the neural
tube or folds to many different sites in the embryo and
differentiate into a large variety of cell types (for review,
see Le Douarin and Kalcheim 1999), providing an impor-
tant paradigm for studying mechanisms of cell differen-
tiation. Heterotopic transplantation experiments have
revealed that, although intrinsic differences in develop-
mental potential between neural crest cell populations
arising at different levels of the neural tube do exist,
development of the neural crest is highly plastic, and
signals from the cellular environment are paramount in
determining its differentiation (see Le Douarin and
Kalcheim 1999). It is not yet clear to what extent plas-
ticity at the population level reflects a lack of commit-
ment or respecification of cell fate at the cellular level
(for review, see Dorsky et al. 2000 and references
therein), although multipotent, putative stem cells have
been isolated from neural crest (Stemple and Anderson
1992).
Insight into the signals involved in cell fate determi-
nation and differentiation has come mainly from studies
involving trunk neural crest, which gives rise to sensory,
sympathetic, and enteric neurons, glia, melanocytes, and
adrenomedullary cells (Le Douarin and Kalcheim 1999).
Cranial neural crest cells that migrate into the branchial
arches yield three important cell types not normally
formed by trunk neural crest: chondrocytes and osteo-
cytes, which generate most of the craniofacial skeleton,
and smooth muscle cells, which surround derivatives of
the branchial arch arteries, including the great arteries in
the thorax. Little is known about the signaling mol-
ecules involved in specification and differentiation of
these three lineages, although in vitro experiments with
trunk neural crest suggest that transforming growth fac-
tor- may be a candidate inducer of smooth muscle dif-
ferentiation (Shah et al. 1996).
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Development of both craniofacial and vascular deriva-
tives of the branchial arch neural crest critically depends
on endothelin signaling, as shown by the effects of mu-
tation of components of the endothelin signaling path-
way (Kurihara et al. 1994, 1995; Clouthier et al. 1998;
Yanagisawa et al. 1998a,b; Miller et al. 2000), and of
pharmacological interference with endothelin signaling
(e.g., Kempf et al. 1998). Neural crest cells migrating into
the branchial arches express the endothelin receptor A
(EdnrA) (Clouthier et al. 1998), whereas endothelin-1
(ET-1) is expressed in a complementary fashion, in the
mesodermal core and the surface ectoderm of the arches,
in the pharyngeal endoderm, and in the endothelium of
the branchial arch arteries (Maemura et al. 1996;
Clouthier et al. 1998).
As in other lineages, the basic domain helix–loop–
helix (bHLH) family of transcription factors figures
prominently in cell fate determination of the neural
crest, and members of this family have been shown to
control specification of the sensory neuron, autonomic
neuron, and melanocyte sublineages (see Christiansen et
al. 2000). ET-1 signaling has been shown to be essential
for expression of the bHLH transcription factors
dHAND/HAND2 and eHAND/HAND1, which are ex-
pressed in partially overlapping domains in the distal
part of the branchial arches (Cserjesi et al. 1995; Thomas
et al. 1998; Clouthier et al. 2000).
The early embryonic lethality caused by loss of func-
tion of dHAND (Srivastava et al. 1997), which is also
expressed in extraembryonic tissues, heart, limb buds,
sympathetic ganglia, and adrenomedullary cells (Srivas-
tava et al. 1995; Charite´ et al. 2000; data not shown), has
so far precluded assessment of its role in development of
the vascular derivatives of the branchial arches. How-
ever, recent work from our laboratory has revealed that
dHAND is essential for craniofacial development (H.
Yanagisawa, J. Charite´, D. McFadden, D. Clouthier, and
E.N. Olson, in prep.). Furthermore, because both in vitro
and in vivo experiments suggested that dHAND is in-
volved in cell fate specification within the sympathetic
neuron lineage (Howard et al. 1999, 2000), we set out to
investigate the regulation of dHAND in the branchial
arch neural crest, as a possible avenue for gaining insight
into the specification of the chondrogenic and smooth
muscle lineages.
Here, we describe the identification of an enhancer
responsible for expression of dHAND in branchial arches
1 and 2. We show that enhancer function is dependent on
the endothelin signaling pathway, and analyze trans-act-
ing factors that bind to it. We provide evidence that the
homeodomain transcription factor Dlx6 binds directly to
this enhancer and is a key intermediate in transduction
of the endothelin signal.
Results
An endothelin-dependent, dHAND branchial
arch enhancer
We have shown previously that a genomic fragment ex-
tending 11 kb upstream of the dHAND initiation codon
(Fig. 1A, construct 1) drives expression in the heart and
in the branchial arches at embryonic day 10.5 (E10.5; Fig.
1B; McFadden et al. 2000). The developmental expres-
sion pattern driven by this region was determined in
transgenic lines carrying construct 1 randomly inte-
grated in the genome. Four independent transgenic lines
exhibited strong expression in heart and branchial
arches, in addition to minor sites of ectopic expression,
which were unique to each line and were therefore re-
garded as caused by elements present at the integration
sites. -Galactosidase expression in the first branchial
arch was first observed around E9.25 (data not shown),
and well-demarcated domains of expression in the distal
part of arches 1 and 2, similar to those of the endogenous
dHAND gene, were established by E9.5 (Fig. 2A). These
domains persisted at E10.5 (Fig. 2B), at which stage more
posterior branchial arches are well developed. These pos-
terior arches did not express the transgene (Fig. 2C,D),
although dHAND is expressed there. This suggests that
a distinct enhancer not included in construct 1 is respon-
sible for expression in arches 3 to 6.
Histological sections of E9.5 embryos revealed that
-galactosidase activity was excluded from the center of
the arches (Fig. 2E, arrowhead). This is consistent with
expression being largely confined to neural crest cells,
because at this stage mesoderm and neural crest cells are
segregated to the core and periphery of the arch, respec-
tively (Trainor and Tam 1995). However, lacking mark-
ers that identify each lineage with cellular resolution, we
cannot exclude that some mesodermal cells express the
transgene as well. At later stages, -galactosidase expres-
sion was observed in the tip and the dorsolateral aspect
of the tongue and in the mandible (Fig. 2F–H). Expression
in the mandible appeared to be regional rather than tis-
sue-specific, comprising much of the ventral connective
tissue in the jaw (Fig. 2G) and the pinnae of the ear (Fig.
2H), but also mesoderm derivatives such as digastric
muscle (data not shown) and submandibular glands (Fig.
2I). Expression in neural crest-derived cartilages was con-
fined to part of the malleus (Fig. 2H), and a few cells in
the proximal part of Meckel’s cartilage (data not shown).
Consistent with the absence of expression in arches 3 to
6 at E9.5–E10.5, no expression was observed at later
stages in the vascular derivatives of the arch arteries of
these branchial arches (data not shown).
To investigate the involvement of the endothelin sig-
naling pathway in activation of the branchial arch en-
hancer, transgenic lines carrying construct 1 were
crossed with EdnrA+/− mice (Clouthier et al. 1998),
and embryos derived from intercrosses of transgenic,
EdnrA+/− mice were stained for -galactosidase activity.
Transgene expression in the heart of E9.5 EdnrA−/−
embryos appeared unaffected as compared with their
EdnrA+/− littermates, but expression in the branchial
arches was completely absent (Fig. 2, cf. J with A). At
E16.75, a few expressing cells were present in the hypo-
plastic tongue and mandible of EdnrA−/− embryos (Fig. 2,
cf. K with G). Aberrant cartilage elements located at the
normal position of the ear ossicles did not contain -ga-
lactosidase-positive cells (Fig. 2L). It should be noted that
Charite´ et al.
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Figure 1. Identification of a branchial arch-specific enhancer. (A) Reporter constructs used in this study. The genomic organization
of dHAND is depicted at the top; coding regions (boxes), relevant restriction sites, and their distance in kilobases from the start of the
coding region are indicated. The lacZ reporter constructs used in this study are schematized underneath; thick black lines and boxes
represent dHAND genomic sequences. Construct 2 extends to −5.49 kb. The Sau3A, SspI, and Sau3A sites used in generating
constructs 8 and 11–14 are located 316, 203, and 121 bp, respectively, upstream of the BamHI site at −6.6 kb. The 5 ends of constructs
9 and 10 are 413 and 196 bp, respectively, upstream of this BamHI site. Presence or absence of -galactosidase expression driven by
these constructs at E10.5 in branchial arches 1 and 2 and in the heart, respectively, is indicated on the right. (Ba) BamHI; (Bg) BglII;
(Bs) BssHII; (Kp) KpnI; (Sa) Sau3A; (Sp) SpeI; (Ss) SspI; (Xh) XhoI. (B–E) Ventral/lateral views of E10.5, Xgal-stained F0 embryos
transgenic for constructs 1, 6, 7, and 13, as indicated at upper right of panels. At least three F0 transgenic embryos were examined for
each construct. B shows -galactosidase activity in heart (h) and the first two branchial arches (black arrowheads). (C) Expression in
heart but not in branchial arches (open arrowheads). (D) Expression in branchial arches (filled arrowheads) but not in heart (open
arrowhead). (E) Expression in heart and branchial arches. Bar, 1 mm.
Regulation of dHAND by endothelin signaling
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several structures, such as the pinnae and the subman-
dibular glands, are missing in these embryos (Clouthier
et al. 1998), making it impossible to establish whether
gene expression in these structures is EdnrA-dependent.
If we assume that the endothelin receptor A is expressed
exclusively in neural crest cells, which is suggested by
its expression pattern (Clouthier et al. 1998), we con-
clude that expression of dHAND in mesodermal struc-
tures at E16.75 reflects a distinct regulatory pathway,
possibly acting through distinct regulatory elements. We
have not attempted to identify these elements, but in-
stead focused on identification of the early-acting,
strictly EdnrA-dependent, branchial arch enhancer.
Deletion analysis defines a 208-bp enhancer
To delineate the cis-acting sequences responsible for
driving expression in the branchial arches, serial
deletions of construct 1 were tested in E10.5 F0 em-
bryos. Expression patterns generated by constructs
2–5 defined the XhoI and BamHI sites at −7.4 and
−6.6 kb as the 5 and 3 boundaries, respectively, of a
region necessary for branchial arch expression.
Construct 6 showed that within construct 1 no se-
quences outside of the XhoI–BamHI region were
capable of driving expression in the branchial arches
(Fig. 1, cf. C with B), and construct 7 showed that
the XhoI–BamHI fragment is sufficient to drive bran-
chial arch expression from a heterologous promoter
(Fig. 1D).
Further deletions of the XhoI–BamHI fragment
were tested in conjunction with the cardiac en-
hancer identified previously (McFadden et al. 2000),
which served as an internal control for integration
sites being permissive to expression. Constructs
8–13 defined a minimally sufficient 208-bp bran-
Figure 2. Developmental expression pattern and
EdnrA-dependence of the dHAND branchial arch en-
hancer. (A–I) -Galactosidase expression driven by
construct 1 in a wild-type or EdnrA+/− background.
(J–L) -Galactosidase expression driven by construct
1 in an EdnrA−/− background. Genotype with respect
to the EdnrA locus is indicated in the top right corner
of each panel. (A) Sagittal section through an E9.5,
27-somite embryo, showing expression in heart (h)
and branchial arches 1 and 2 (ba1,2). (B) Ventral view
of E10.5 embryo, posterior part removed, showing ex-
pression in branchial arches and heart. (C,D) Frontal/
transverse sections through E10.5 embryo, showing
expression in branchial arch 2 and lack of expression
in branchial arches 3–6. (E) Sagittal section through
the branchial arches of the embryo shown inA, show-
ing lack of expression in the core (arrowhead) of the
first branchial arch (ba1). (F–I) Frontal sections
through the head of an E16.75 embryo. (F) Strong ex-
pression in the distal part of the mandible (ma) and
tongue (t). (G) Section is cut at a more proximal level,
showing expression dorsolaterally in the tongue, and
in the ventral part of the mandible, in connective
tissue (ct) and in the mesenchymal component of the
incisor tooth bud (in), but not in Meckel’s cartilage
(mc). (H) Section is cut at the level of the middle ear,
showing expression in the pinna (pi) and in part of the
malleus (ml). (I) Another part of the section shown in
H; -galactosidase expression is observed in the mes-
enchyme of the submandibular gland (sm). (J–L) Sec-
tions through EdnrA−/− embryos. (J) Sagittal section,
comparable to the one shown in A, through an E9.5,
27-somite embryo, showing strong expression in the
heart but lack of expression in the branchial arches.
(K) Frontal section through the head of an E16.75 lit-
termate of the embryo shown in F–I, at approxi-
mately the same level as the section shown in G,
showing few expressing cells (arrowheads) in the hy-
poplastic tongue (t) and mandible (ma). (L) Section
corresponding to the one shown inH, showing lack of
expression in cartilage elements possibly represent-
ing rudimentary middle ear ossicles (asterisk). (aa)
aortic arch artery; (em) external acoustic meatus; (ic) incus; (mx) maxilla; (ph) pharynx; (st) stapes. In all panels except B, dorsal is
toward the top; in A, E, and J, anterior is toward the left, in B, toward the top. Bars, 0.1 mm.
Charite´ et al.
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chial arch enhancer fragment (Fig. 1E), hereafter re-
ferred to as SspBam208; deletion of either the 5
or the 3 part of this fragment abolished branchial
arch expression (constructs 11 and 12; data not
shown).
Binding of EdnrA-dependent factors to SspBam208
Comparison of the SspBam208 sequence with the corre-
sponding region from chick revealed a high degree of
homology (Fig. 3A), providing few clues with regard to
Figure 3. Trans-acting factors binding to SspBam208. (A) Sequence comparison between SspBam208 and the corresponding region
from chick. The SspI, Sau3AI, and BamHI sites and the position of oligonucleotides S1–S10 are indicated below the mouse sequence.
(B) Electrophoretic mobility shift assays with oligonucleotides S1–S10 and whole cell extracts from the first branchial arch of EdnrA−/−
(−/−), and a mixture of heterozygous and wild-type (+/) embryos. Complexes that are up-regulated or down-regulated in the EdnrA−/−
background are indicated with white and black arrowheads, respectively.
Regulation of dHAND by endothelin signaling
GENES & DEVELOPMENT 3043
 Cold Spring Harbor Laboratory Press on February 14, 2011 - Published by genesdev.cshlp.orgDownloaded from 
putative transcription factor binding sites essential for
enhancer function. Homology between the chick and
mouse genomic sequences was confined to the neural
crest enhancer and was not observed in surrounding ge-
nome regions. To identify trans-acting factors involved
in mediating signaling from the EdnrA to SspBam208,
10 double-stranded oligonucleotides covering the Ssp-
Bam208 sequence (see Fig. 3A) were used as probes in
electrophoretic mobility shift assays (EMSAs) with pro-
tein extracts prepared from the first branchial arches of
EdnrA−/− embryos and of wild-type or heterozygous lit-
termates (Fig. 3B). No obvious differences between these
extracts were observed with oligonucleotides S1, S2, S5,
and S10, but the remaining oligonucleotides did reveal
differential binding patterns. Differences included clear
decreases as well as increases of certain complexes (in-
dicated with black and white arrowheads, respectively,
in Fig. 3B) upon removal of endothelin receptor function.
Additional, less obvious differences were also apparent,
but these could not be consistently quantitated. These
observations suggested the existence of several potential,
positive as well as negative regulatory proteins that
could be involved in transducing the endothelin signal.
Interestingly, oligonucleotides S6, S7, S8, and S9
yielded EdnrA-dependent complexes migrating at ex-
actly the same level in the gel, and the complexes formed
on S7 and S9 that were up-regulated in the EdnrA−/−
background also comigrated. Because oligonucleotides
S6–S9 all contain an ATTA motif, which forms the core
binding site for many homeodomain-containing tran-
scription factors, and because expression of several ho-
meobox genes had been shown to be dependent on en-
dothelin signaling (Clouthier et al. 1998, 2000), we in-
vestigated whether the ATTA motifs are important for
enhancer function.
Homeodomain binding sites are essential for enhancer
activity and binding of EdnrA-dependent factors
Oligonucleotides S6Sac, S7Cla, S8Xho, and S9Hind, con-
taining mutations in the ATTAmotifs (see Fig. 4A), were
tested in EMSAs with branchial arch extracts. In
each case, the ATTA mutation abolished formation of
the endothelin-dependent complex (Fig. 4B, cf. lane 3
with lane 1, black arrowhead; data not shown). For S7
and S9, formation of the complex that was up-regulated
in the EdnrA−/− background was abolished as well (Fig.
4B, cf. lane 4 with lane 2, white arrowhead; data not
shown).
Enhancer activity of SspBam208 containing all four
ATTA mutations was tested, again using the cardiac
enhancer as an internal control (construct 14, Fig. 1A).
F0 embryos carrying construct 14 showed strong -
galactosidase expression in the heart, but lacked expres-
sion in the branchial arches (Fig. 4C), showing that one
or more of the ATTA motifs is essential for enhancer
function.
Figure 4. Homeodomain binding sites are
essential for enhancer activity and for
binding of EdnrA-dependent factors. (A)
Sequences of oligonucleotides S6–S9 and
their mutant versions, containing several
base changes, as indicated, destroying the
ATTA motifs. (B) EMSA with wild-type
and EdnrA−/− first arch extract and oligo-
nucleotides S7 and S7cla. Both the EdnrA-
dependent complex (lane 1, black arrow-
head), and the complex up-regulated in the
absence of endothelin signaling (lane 2,
white arrowhead; note distance to the
ubiquitous complex indicated by the aster-
isk) are not formed on S7cla (lanes 3 and 4,
respectively). (C) E10.5 F0 embryo carrying
construct 14, stained with Xgal. -Galac-
tosidase activity is observed in the heart
(h), but not in the branchial arches (arrow-
heads).
Charite´ et al.
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Identification of Dlx6 as an EdnrA-dependent
enhancer binding factor
We sought to determine whether the EdnrA-dependent
complexes identified in EMSAs represented any of sev-
eral homeodomain proteins expressed in the branchial
arches that were shown to depend on endothelin signal-
ing (Clouthier et al. 1998, 2000). We initially focused on
gsc and Dlx3, because the expression domains of these
genes in the first branchial arch overlap at least in part
with that of dHAND. However, expression of dHAND in
the branchial arches of E10.5 gsc−/− embryos (a gift of R.
Behringer, M.D. Anderson Cancer Center, Houston, TX)
was not obviously different from that in wild-type litter-
mates as determined by whole mount in situ hybridiza-
tion (data not shown). Furthermore, in EMSAs, Dlx3 pro-
tein expressed in COS cells did not comigrate with the
EdnrA-dependent complex (data not shown).
In the course of these experiments we did, however,
find that formation of this complex could be abolished
by an antibody directed against the homeodomain of
Distal-less (Dll; a gift of G. Panganiban, University of
Wisconsin, Madison; Fig. 5A, cf. lane 5 with lanes 3 and
4), indicating that Dlx proteins are present in this com-
plex. Further experiments revealed that neither Dlx2 nor
Dlx5 comigrated with the complex (data not shown), but
that Dlx6 did migrate at exactly the same position in the
gel (Fig. 5A, cf. lane 2 with lane 3). Binding of Dlx6 was
abolished by anti-Dll (Fig. 5A, cf. lane 6 with lane 2) and
by mutation of the ATTA motif (Fig. 5A, cf. lane 8 with
lane 2). These data suggest that Dlx6 is the major EdnrA-
dependent factor binding to SspBam208. We cannot for-
mally exclude that the binding of Dlx6 to SspBam208
depends on an endothelin-dependent binding partner
that is somehow expressed in COS cells as well. How-
ever, expression of Dlx6 was undetectable in the distal
part of the branchial arches of EdnrA−/− embryos (Fig. 5,
cf. E with C), whereas expression in the proximal part of
the arch appeared to be independent of EdnrA signaling
(Fig. 5E, closed arrowhead). Therefore, we favor the par-
simonious conclusion thatDlx6 is the key EdnrA-depen-
dent component of the EdnrA-dependent complex in the
wild-type first arch.
Discussion
A distinct developmental program for the mandibular
and hyoid arch
We have described the identification and analysis of an
enhancer responsible for expression of dHAND in bran-
chial arches 1 and 2, the mandibular and hyoid arches.
To our knowledge, this is the first description of an en-
dothelin-responsive enhancer with a defined activity in
vivo. Our finding of a distinct enhancer dedicated to
driving dHAND expression in arches 1 and 2 versus the
more posterior arches is surprising, but consistent with
the distinct morphological development of these arches,
which in more primitive gnathostomes form the jaw and
its supportive apparatus, respectively. These structures
are thought to have evolved at an early stage in gnatho-
stome evolution, as specializations of the gill bars
formed by the more posterior branchial arches. It re-
Figure 5. Involvement of Dlx6 in transduction of endothelin
signaling to SspBam208. (A) Identification of the EdnrA-depen-
dent complex. EMSA with oligonucleotides S7 and S7cla, and
extracts from untransfected COS-1 cells (lanes 1,9), COS-1 cells
transfected with pSG5-Dlx6 (lanes 2,6,8), or from branchial
arches of wild-type (lanes 3,5,7) or EdnrA−/− (lane 4) embryos,
showing that Dlx6 comigrates with the EdnrA-dependent com-
plex (lanes 2 and 3, black arrowheads), that binding of both is
dependent on the integrity of the ATTA motif (cf. lanes 7 and 8
with lanes 3 and 2), and is abolished by incubation with anti-Dll
(cf. lanes 5 and 6 with lanes 3 and 2). (B–D) Dependence of Dlx6
expression on endothelin signaling. Brightfield (B,D) and dark-
field (C,E) images of frontal sections through the head of E10.5
wild-type (B,C) and EdnrA−/− (D,E) embryos. Dlx6 is expressed
in the first branchial arch (ba1) of wild-type embryos (arrow-
heads in B,C), but not in the distal part of the EdnrA−/− first arch
(open arrowheads in D,E), although expression is still observed
in the proximal region of the arch (filled arrowheads inD,E). Bar,
0.1 mm.
Regulation of dHAND by endothelin signaling
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mains to be established whether the presence of a dedi-
cated arch 1/2 enhancer is related to different functional
requirements of dHAND in these versus more posterior
arches, for example, with respect to expression level, or
exclusively reflects differences in upstream signaling
pathways that may be contingent upon differences in
development, including the degeneration of the bran-
chial arch arteries and increased growth, of arch 1 and 2.
The existence of a distinct developmental program for
the mandibular and hyoid arches is supported by the
finding that mutations in several complementation
groups uncovered by mutagenesis screens in zebrafish
specifically affect skeletal elements derived from arches
1 and 2, leaving more posterior structures intact (Pi-
otrowski et al. 1996). Interestingly, the most severe an-
terior arch phenotype is observed in the sucker mutant,
caused by a missense mutation in the et-1 gene that abol-
ishes ET-1 function (Miller et al. 2000). However, sucker
not only affects development of arches 1 and 2, but also
of arches 3 and 4, and, infrequently, 5 (Piotrowski et al.
1996; Miller et al. 2000), suggesting quantitative, rather
than qualitative differences in dependence on ET-1 sig-
naling between branchial arches. This appears to be re-
flected in the expression of dHAND in sucker mutant
embryos, which is abolished in the first branchial arch,
but only partly down-regulated in more posterior arches
(Miller et al. 2000). Whether dHANDwould be classified
as an anterior arch gene remains to be established, as
dHAND mutant zebrafish, like dHAND mutant mice
(Srivastava et al. 1997), die before their craniofacial phe-
notype can be assessed (Yelon et al. 2000).
Role of Dlx6 in regulation of dHAND
We have shown that the activity of the dHAND arch 1/2
enhancer, like that of the endogenous dHAND gene, is
critically dependent on EdnrA function, on the one hand,
and on the integrity of putative homeodomain binding
sites in the enhancer, on the other. Our data suggest that
the homeodomain transcription factor Dlx6 forms the
connection between these two observations. First, al-
though branchial arch expression of several homeobox
genes is down-regulated in EdnrA−/− mice (Clouthier et
al. 1998, 2000), our EMSAs with SspBam208 oligo-
nucleotides revealed a single EdnrA-dependent tran-
scription factor binding to each of the homeodomain
binding sites, which was identified as Dlx6 based on
comigration and on reactivity with anti-Dll. Second, al-
though no data are available for Dlx6 specifically, Dlx
proteins can activate or repress transcription depending
on the target gene involved (e.g., Benson et al. 2000 and
references therein). Finally, Dlx6 expression is abolished
in the ventral part of EdnrA−/− branchial arches, where
dHAND is normally expressed. Together, these data
strongly support the conclusion that Dlx6 is an activator
of dHAND transcription in at least the first branchial
arch, acting as a transducer of EdnrA-mediated signal-
ing. The specificity of the interaction between Dlx6 and
SspBam208 observed in EMSAs is underscored by the
observation that, although expression ofDlx5 in the ven-
tral part of the branchial arches is, like that of Dlx6,
dependent on EdnrA function, dHAND expression in the
branchial arches of Dlx5−/− embryos is not obviously af-
fected (data not shown). A direct test of the epistatic
relationship between Dlx6 and dHAND must await tar-
geted inactivation of the Dlx6 gene.
The intracellular signaling pathways that operate in
neural crest cells to transduce the signal from the acti-
vated endothelin receptor A to ET-1 target genes are un-
known; however, the craniofacial phenotype caused by
loss of function of the G protein -subunits Gq and
G11 may hint at their possible involvement in this
pathway (Offermanns et al. 1998).
Complex control of dHAND expression
Because Dlx6 expression in the branchial arches is more
extensive than that of dHAND, and only the ventral part
of the Dlx6 expression domain is ET-1-dependent, addi-
tional factors must act on SspBam208 in conjunction
with Dlx6 to restrict expression to the proper domain.
Although Dlx6 appears to be the major positively acting
factor controlling dHAND branchial arch expression as
identified by our EMSAs, these experiments also re-
vealed an unexpectedly complex set of potentially nega-
tive inputs on SspBam208 that are regulated by the en-
dothelin signaling pathway. We have not determined the
binding sites for these factors in any detail, and currently
have no corroborating evidence for the importance of
their interaction with SspBam208 in vivo. It is clear,
however, that some of these factors do not require ATTA
motifs, whereas binding sites for others may in fact over-
lap the ATTA motifs used by Dlx6, suggesting that en-
dothelin-dependent expression of dHAND is stringently
controlled, requiring removal of repressors as well as
binding of Dlx6. Further experiments are necessary to
test this hypothesis.
Our findings suggest that binding of Dlx6 is necessary
for activity of the dHAND branchial arch enhancer, but
it is clearly not sufficient, as deletion of the SspI–Sau3AI
fragment from SspBam208 abolishes enhancer function,
despite the fact that all Dlx6 binding sites are retained in
the remaining Sau3AI–BamHI fragment. Whether a
similar statement can be made with regard to endothelin
signaling is less obvious. Although it is conceivable that
an equilibrium between positive and negative regulators
that are differentially controlled by endothelin signaling
could be sufficient to generate the proper dHAND ex-
pression domain, it is more likely that additional signal-
ing pathways converge on SspBam208, because although
both dHAND and eHAND are dependent on endothelin
signaling, their expression domains overlap only in the
distal part of the branchial arches (Cserjesi et al. 1995;
Thomas et al. 1998; Clothier et al. 2000). This suggests
that they respond differentially to additional, positional
information within the branchial arches, perhaps to sig-
nals emanating from a distal signaling center. Compara-
tive analysis of the dHAND and eHAND branchial arch
enhancers should be helpful in further elucidating these
upstream regulatory pathways.
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Dlx and HAND genes, endothelins, and cell
fate specification
It has been hypothesized that the neural crest evolved
from Rohon–Beard-like sensory neurons, which emigrate
from the neural tube at an early stage of development
(Fritzsch and Northcutt 1993), and this appears to be
supported by recent genetic evidence (Artinger et al.
1999). How these cells acquired the potential to differ-
entiate into cartilage and bone is a question upon which
no experimental data currently seem to bear in an obvi-
ous way. It is, however, intriguing that the Dll gene of
the acraniate amphioxus, which does not have a neural
crest, is highly up-regulated at the border of the embry-
onic ectoderm and neuroectoderm (Holland et al. 1996),
apparently analogous to expression of Dlx5 in presump-
tive premigratory neural crest in mouse (Yang et al.
1998), and that besides their expression in the branchial
arches, both Dlx5 and Dlx6 are expressed in differenti-
ating osteoblasts in all developing bones (see, e.g., Acam-
pora et al. 1999). Dlx5 has been shown to regulate genes
involved in osteogenesis in vitro (e.g., Benson et al.
2000), and knockout studies have confirmed that it is
involved in bone differentiation in addition to being nec-
essary for development of the craniofacial skeleton
(Acampora et al. 1999; Depew et al. 1999).
Interpretation of cranial cartilage morphogenesis in
the zebrafish anterior arch mutants, including sucker,
has led Kimmel and coworkers to speculate that one ef-
fect of ET-1 signaling is the specification of a ventral
identity in skeletogenic neural crest, which would be-
come dorsal by default in the absence of endothelin sig-
naling (Kimmel et al. 1998, 2001). This would fit with
the finding in chick that dorsally fated neural crest cells
give rise to ventral cartilages when allowed to migrate
into the ventral part of the branchial arch (Baker et al.
1997), suggesting environmental control of ventral cell
fate. However, in mouse, loss of EdnrA function also
affects putatively dorsal skeletal elements, although less
severely than ventral structures (Clouthier et al. 1998).
Whether these discrepancies are caused by species-spe-
cific differences in dorsoventral patterning or interde-
pendence of morphogenesis of dorsal and ventral ele-
ments, or by compensating activity of other, as yet un-
identified, endothelin isoforms in zebrafish, remains to
be established. Although ectopic expression studies are
necessary to confirm that ET-1 actually induces ventral
cell fates, the results described here, and the effects of
deletion of the dHAND branchial arch enhancer (H.
Yanagisawa, J. Charite´, D. McFadden, D. Clouthier, and
E.N. Olson, in prep.) suggest that dHAND could be a key
downstream selector gene for the ventral cell fate.
Forward genetics studies in mouse have uncovered es-
sential functions for several transcription factors in de-
velopment of the craniofacial skeleton, loss of function
often resulting in partially overlapping defects in pat-
terning of neural crest-derived structures. None of these
essential patterning genes has yet been implicated in
congenital malformations in man, possibly owing to the
severity of their loss-of-function phenotypes (Wilkie and
Morriss-Kay 2001). Given the early embryonic lethality
of dHAND null mice, it is likely that mutations in the
dHAND coding region that cause significant loss of func-
tion will not be recovered among live births. Whether
mutations in the branchial arch enhancer described here
may be causally involved in congenital malformations,
and whether arch-1/2-specific disorders such as Treach-
er–Collins syndrome involve dHAND as a downstream
effector, are issues that bear further investigation.
Materials and methods
DNA constructs
Reporter constructs 1–5 and 8–14 contain dHAND genomic se-
quences cloned upstream of the lacZ gene in plasmid pAUG-
LacZ, using a BssHII site most proximal to the ATG in the
5-untranslated region of dHAND. Construct 1 has been de-
scribed previously (McFadden et al. 2000). Deletion constructs
were generated using convenient genomic clones (constructs 2,
14), internal restriction sites, or digestion with exonuclease III
(constructs 9, 10, 12). For construct 7, a XhoI–BamHI dHAND
genomic fragment was cloned upstream of the hsp68 promoter
in plasmid hsp68lacZ. Vector sequences were removed prior to
microinjection.
For pSG5–Dlx6, the complete murine Dlx6 cDNA was con-
structed by RT–PCR, sequenced (Pfeffer et al. 2001), and cloned
into the EcoRI site of the pSG5 expression vector (Stratagene).
Chick dHAND genomic clones were isolated from a chick
genomic library (Clontech) using the chick bHLH region as a
probe.
In situ hybridization
In situ hybridization on mouse embryo sections was performed
as described previously (Shelton et al. 2000), using 35S-labeled
mX6EX3/4 probe. This cDNA probe was engineered to contain
the entire exon 3 and part of exon 4 of mouse Dlx6, excluding
the flanking homeobox and repetitive sequences. Specificity of
this probe was tested by Northern analysis.
Generation and analysis of transgenic embryos and mice
F0 transgenic mouse embryos were generated as described pre-
viously (McFadden et al. 2000). Stable transgenic lines carrying
construct 1 were established in the FVB strain. These lines were
crossed with EdnrAmutant mice on the 129S6SvEv background
(Clouthier et al. 1998), and progeny were intercrossed for a few
generations, generating double heterozygous mice on a mixed
FVB/129 background. Embryos were fixed and stained with Xgal
as described in Charite´ et al. (1998), but for embryos of 11.5 d
and older, the staining solution was supplemented with 0.1%
NP-40, and for embryos of 13.5 d and older, 0.2% sodium de-
oxycholate was included as well.
Whole-cell extracts and electrophoretic mobility shift assays
Whole-cell extracts from COS-1 cells, untransfected or trans-
fected with pSG5–Dlx6 using Fugene-6 reagent (Roche), were
prepared as described by Charite´ et al. (1998). For whole cell
branchial arch extracts, the distal parts of the first branchial
arches of several E10.25–E10.5 embryos were dissected in TBS
(Charite´ et al. 1998), pooled, and stored in liquid nitrogen until
preparation of extracts. To prepare extracts from EdnrA null and
matching wild-type and/or heterozygous branchial arches, arch
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pairs from individual embryos were stored in liquid nitrogen,
and embryos were genotyped by PCR or Southern analysis or by
using a construct 1 transgene crossed into the EdnrA knockout
background as an indicator, scoring for expression of the -ga-
lactosidase reporter in the second branchial arch. Arches were
then taken up in a small volume of TBS, pooled according to
genotype, and processed as described above.
Electrophoretic mobility shift assays were performed essen-
tially as described by Charite´ et al. (1998), using 1 µL of extract
per reaction and incubation for 10–15 min at room temperature.
Then 1 µL of rabbit anti-Dll antibody (Panganiban et al. 1995)
was added before addition of the probe, or after formation of the
complex, with similar results. Oligonucleotides were (plus
strand given): S1, TAAGCTTGATATTTCTCCCTCTTTT
TTTTT; S2, TTTTTGAGAATTTGTCCCTGTCTTGCTTTA;
S3, TCTTGCTTTATTTGTTTGTGTGAAATTTAG; S4, TGA
AATTTAGTTTGAAAGGAGATCAGAGAG; S5, GATCAG
AGAGAGCAGGAGGGGTTTGTAATA; S6, GTTTGTAATA
AGAGAATGACCGAATGACCC; S7, CGAATGACCCAAAG-
GCTGATTATCTATCAT; S8, TATCTATCATTAACTGGA
GACTTGGTGTAC; S9, CTTGGTGTACCCAAATTACCAG-
GAAGACCT; S10, AGGAAGACCTCAGTCTGCCGGAC-
TAGTTCT; S6Sac, GTTTGAGCTCAGAGAATGACCGAAT-
GACCC; S7Cla, CGAATGACCCAAAGGCTATCGATCTAT
CAT; S8Xho, TATCTATCTCGAGCTGGAGACTTGGTGTAC;
S9Hind, CTTGGTGTACCCAAAGCTTCAGGAAGACCT.
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